FOXF1 and gastrointestinal stromal tumor: Furthermore, FOXF1 was found to be required for oncogenic potential of tumor cells in rhabdomyosarcomas (Milewski et al, 2017; Milewski et al, 2021) and gastrointestinal stromal tumors (Ran et al, 2018).